These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 23202949)

  • 41. MiRNAs from
    Baulina N; Osmak G; Kiselev I; Popova E; Boyko A; Kulakova O; Favorova O
    Cells; 2019 Feb; 8(2):. PubMed ID: 30743997
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MicroRNAs as T Lymphocyte Regulators in Multiple Sclerosis.
    Wang L; Liang Y
    Front Mol Neurosci; 2022; 15():865529. PubMed ID: 35548667
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human miR-26a-5p regulates the glutamate transporter SLC1A1 (EAAT3) expression. Relevance in multiple sclerosis.
    Potenza N; Mosca N; Mondola P; Damiano S; Russo A; De Felice B
    Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):317-323. PubMed ID: 28962897
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum Exosome MicroRNAs Predict Multiple Sclerosis Disease Activity after Fingolimod Treatment.
    Ebrahimkhani S; Beadnall HN; Wang C; Suter CM; Barnett MH; Buckland ME; Vafaee F
    Mol Neurobiol; 2020 Feb; 57(2):1245-1258. PubMed ID: 31721043
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Is It worth Considering Circulating microRNAs in Multiple Sclerosis?
    Jagot F; Davoust N
    Front Immunol; 2016; 7():129. PubMed ID: 27092141
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MicroRNAs as novel regulators of neuroinflammation.
    Ksiazek-Winiarek DJ; Kacperska MJ; Glabinski A
    Mediators Inflamm; 2013; 2013():172351. PubMed ID: 23983402
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls.
    Keller A; Leidinger P; Lange J; Borries A; Schroers H; Scheffler M; Lenhof HP; Ruprecht K; Meese E
    PLoS One; 2009 Oct; 4(10):e7440. PubMed ID: 19823682
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MicroRNAs: Key Regulators in the Central Nervous System and Their Implication in Neurological Diseases.
    Cao DD; Li L; Chan WY
    Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27240359
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential microRNA expression in blood in multiple sclerosis.
    Søndergaard HB; Hesse D; Krakauer M; Sørensen PS; Sellebjerg F
    Mult Scler; 2013 Dec; 19(14):1849-57. PubMed ID: 23773985
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of miRNAs and their potential effects on multiple sclerosis related pathways using ın silico analysis.
    Erkal B; Vural Korkut S
    Mult Scler Relat Disord; 2022 Mar; 59():103642. PubMed ID: 35121245
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MicroRNA-142 regulates inflammation and T cell differentiation in an animal model of multiple sclerosis.
    Talebi F; Ghorbani S; Chan WF; Boghozian R; Masoumi F; Ghasemi S; Vojgani M; Power C; Noorbakhsh F
    J Neuroinflammation; 2017 Mar; 14(1):55. PubMed ID: 28302134
    [TBL] [Abstract][Full Text] [Related]  

  • 52. miRNAs in cerebrospinal fluid identify patients with MS and specifically those with lipid-specific oligoclonal IgM bands.
    Quintana E; Ortega FJ; Robles-Cedeño R; Villar ML; Buxó M; Mercader JM; Alvarez-Cermeño JC; Pueyo N; Perkal H; Fernández-Real JM; Ramió-Torrentà L
    Mult Scler; 2017 Nov; 23(13):1716-1726. PubMed ID: 28067602
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of microRNAs in multiple sclerosis.
    Mansoor SR; Ghasemi-Kasman M; Yavarpour-Bali H
    Int Rev Immunol; 2022; 41(2):57-71. PubMed ID: 32997552
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Erythrocyte microRNA sequencing reveals differential expression in relapsing-remitting multiple sclerosis.
    Groen K; Maltby VE; Lea RA; Sanders KA; Fink JL; Scott RJ; Tajouri L; Lechner-Scott J
    BMC Med Genomics; 2018 May; 11(1):48. PubMed ID: 29783973
    [TBL] [Abstract][Full Text] [Related]  

  • 55. miR-155 Dysregulation and Therapeutic Intervention in Multiple Sclerosis.
    McCoy CE
    Adv Exp Med Biol; 2017; 1024():111-131. PubMed ID: 28921467
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasmatic microRNA as Potential Biomarkers of Multiple Sclerosis: Literature Review.
    Kacperska MJ; Walenczak J; Tomasik B
    Adv Clin Exp Med; 2016; 25(4):775-9. PubMed ID: 27629854
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The miRNA Expression Profile of Experimental Autoimmune Encephalomyelitis Reveals Novel Potential Disease Biomarkers.
    Venkatesha SH; Dudics S; Song Y; Mahurkar A; Moudgil KD
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544973
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Selected extracellular microRNA as potential biomarkers of multiple sclerosis activity--preliminary study.
    Kacperska MJ; Jastrzebski K; Tomasik B; Walenczak J; Konarska-Krol M; Glabinski A
    J Mol Neurosci; 2015 May; 56(1):154-63. PubMed ID: 25487315
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The First Dose of Fingolimod Affects Circulating Extracellular Vesicles in Multiple Sclerosis Patients.
    Sáenz-Cuesta M; Alberro A; Muñoz-Culla M; Osorio-Querejeta I; Fernandez-Mercado M; Lopetegui I; Tainta M; Prada Á; Castillo-Triviño T; Falcón-Pérez JM; Olascoaga J; Otaegui D
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30126230
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Role of MicroRNAs in Repair Processes in Multiple Sclerosis.
    Duffy CP; McCoy CE
    Cells; 2020 Jul; 9(7):. PubMed ID: 32708794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.